BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ikeda C, Haga H, Makino N, Inuzuka T, Kurimoto A, Ueda T, Matsuda A, Kakizaki Y, Ishizawa T, Kobayashi T, Sugahara S, Tsunoda M, Suda K, Ueno Y. Utility of Claudin-3 in extracellular vesicles from human bile as biomarkers of cholangiocarcinoma. Sci Rep 2021;11:1195. [PMID: 33441949 DOI: 10.1038/s41598-021-81023-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Oh S, Yang H, Oh HR, Seo MR, Lee CH, Kim YH, Choi JY, Kim NY, Cheon GJ, Kang KW, Shin YK, Youn H. Visualization of a novel human monoclonal antibody against Claudin-3 for targeting ovarian cancer. Nucl Med Biol 2022;114-115:135-42. [PMID: 35501237 DOI: 10.1016/j.nucmedbio.2022.04.003] [Reference Citation Analysis]
2 Li Y, Li K, Liu Z, Tang Y, Hu X, Li X, Shi A, Zhao L, Shu L, Lian S, Yan Z, Huang S, Sheng G, Song Y, Liu Y, Huan F, Zhang M, Zhang Z. Research progress of bile biomarkers and their immunoregulatory role in biliary tract cancers. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1049812] [Reference Citation Analysis]
3 Lucotti S, Kenific CM, Zhang H, Lyden D. Extracellular vesicles and particles impact the systemic landscape of cancer. EMBO J 2022;:e109288. [PMID: 36052513 DOI: 10.15252/embj.2021109288] [Reference Citation Analysis]
4 Bao F, Liu J, Chen H, Miao L, Xu Z, Zhang G. Diagnosis Biomarkers of Cholangiocarcinoma in Human Bile: An Evidence-Based Study. Cancers (Basel) 2022;14:3921. [PMID: 36010914 DOI: 10.3390/cancers14163921] [Reference Citation Analysis]
5 Gongye X, Tian M, Xia P, Qu C, Chen Z, Wang J, Zhu Q, Li Z, Yuan Y. Multi-omics analysis revealed the role of extracellular vesicles in hepatobiliary & pancreatic tumor. J Control Release 2022;350:11-25. [PMID: 35963466 DOI: 10.1016/j.jconrel.2022.08.010] [Reference Citation Analysis]
6 Xu ZZ, Fei SK. Research progress of tight junction protein claudin-3 in hepatobiliary systemic diseases. Shijie Huaren Xiaohua Zazhi 2022; 30(15): 668-673 [DOI: 10.11569/wcjd.v30.i15.668] [Reference Citation Analysis]
7 Shen N, Zhu B, Zhang W, Nian B, Xu X, Yu L, Ruan X, Chen S, Liu Y, Cao X, Shi X, Li Z, Huang X, Wang X, Chen C, Xiong L, Zhang D, Fu X, Zhang Y. Comprehensive Evaluation and Application of a Novel Method to Isolate Cell-Free DNA Derived From Bile of Biliary Tract Cancer Patients. Front Oncol 2022;12:891917. [PMID: 35600407 DOI: 10.3389/fonc.2022.891917] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zhao K, Li X, Shi Y, Lu Y, Qiu P, Deng Z, Yao W, Wang J. Exosomes in the tumor microenvironment of cholangiocarcinoma: current status and future perspectives. J Transl Med 2022;20. [DOI: 10.1186/s12967-022-03294-x] [Reference Citation Analysis]
9 Ney A, Garcia-Sampedro A, Goodchild G, Acedo P, Fusai G, Pereira SP. Biliary Strictures and Cholangiocarcinoma - Untangling a Diagnostic Conundrum. Front Oncol 2021;11:699401. [PMID: 34660269 DOI: 10.3389/fonc.2021.699401] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Sato K, Baiocchi L, Kennedy L, Zhang W, Ekser B, Glaser S, Francis H, Alpini G. Current Advances in Basic and Translational Research of Cholangiocarcinoma. Cancers (Basel) 2021;13:3307. [PMID: 34282753 DOI: 10.3390/cancers13133307] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]